Emmanuela is a viral oncologist. During her PhD she presented a novel, targeted therapeutic strategy to treat lymphomas caused by EBV and a closely related virus, KSHV, which often have limited options for treatment in the clinic.

As a Schmidt Science Fellow, Emmanuela worked with Professor Michael Inouye at the University of Cambridge to study the role of iron-deficiency anemia in cardiometabolic disease outcomes in ancestrally diverse global populations. By applying powerful data science techniques to multi-omics data, Emmanuela’s research will help us understand how genomic and phenotypic features associated with iron deficiency can be used to treat cardiometabolic diseases better worldwide.

She continues her work as a Postdoctoral Fellow at the University of Cambridge.

Growing up in Cameroon, Emmanuela developed an interest in global health where the negative impacts of poor infrastructure and limited funding on health outcomes could be seen all around. Given the growing burden of chronic diseases in low to middle income countries, Emmanuela hopes her research will advance our understanding of the unique factors that drive chronic diseases in these settings and that these findings will improve our clinical approaches to treating these diseases in diverse global settings.